Home/Filings/4/0000899243-21-008465

4//SEC Filing

LEVIN MARK J 4

Accession 0000899243-21-008465

CIK 0001628171other

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:12 PM ET

Size

19.8 KB

Accession

0000899243-21-008465

Insider Transaction Report

Form 4

Period: 2021-02-24

Revolution Medicines, Inc.RVMD

Third Rock Ventures GP III, L.P.

10% Owner

Transactions

Other
Common Stock
2021-02-24−1,500,000→ 5,524,031 total

Holdings

Common Stock
(indirect: See footnote)
1,909,317
Common Stock
(indirect: See footnote)
0
Common Stock
(indirect: See footnote)
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
(indirect: See footnote)
129,256
Common Stock
(indirect: See footnote)
129,258

TRV GP III, LLC

10% Owner

Transactions

Other
Common Stock
2021-02-24−1,500,000→ 5,524,031 total

Holdings

Common Stock
(indirect: See footnote)
1,909,317
Common Stock
(indirect: See footnote)
0
Common Stock
(indirect: See footnote)
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
(indirect: See footnote)
129,256
Common Stock
(indirect: See footnote)
129,258

STARR KEVIN P

10% Owner

Transactions

Other
Common Stock
2021-02-24−1,500,000→ 5,524,031 total

Holdings

Common Stock
(indirect: See footnote)
129,258
Common Stock
(indirect: See footnote)
1,909,317
Common Stock
(indirect: See footnote)
0
Common Stock
(indirect: See footnote)
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
(indirect: See footnote)
129,256

TEPPER ROBERT I

10% Owner

Transactions

Other
Common Stock
2021-02-24−1,500,000→ 5,524,031 total

Holdings

Common Stock
(indirect: See footnote)
1,909,317
Common Stock
(indirect: See footnote)
0
Common Stock
(indirect: See footnote)
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
(indirect: See footnote)
129,256
Common Stock
(indirect: See footnote)
129,258

LEVIN MARK J

10% Owner

Transactions

Other
Common Stock
2021-02-24−1,500,000→ 5,524,031 total

Holdings

Common Stock
(indirect: See footnote)
1,909,317
Common Stock
(indirect: See footnote)
0
Common Stock
(indirect: See footnote)
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
(indirect: See footnote)
129,256
Common Stock
(indirect: See footnote)
129,258

Third Rock Ventures III, L.P.

10% Owner

Transactions

Other
Common Stock
2021-02-24−1,500,000→ 5,524,031 total

Holdings

Common Stock
(indirect: See footnote)
1,909,317
Common Stock
(indirect: See footnote)
0
Common Stock
(indirect: See footnote)
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
(indirect: See footnote)
129,256
Common Stock
(indirect: See footnote)
129,258

Footnotes (8)

[F1]On February 24, 2021, Third Rock Ventures III, L.P. ("TRV III") distributed for no consideration, 1,500,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP III, L.P. ("TRV GP II"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
[F2]These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares
[F3]These shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II"). The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Levin, Starr and Tepper. Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
[F4]Third Rock Ventures IV, L.P. ("TRV IV") directly holds 1,419,900 shares of Common Stock of the Issuer. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of the reporting persons and TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of
[F5]The shares are directly held by Levin. Includes Shares received in the distributions described in footnote (1) above.
[F6]The shares are directly held by Levin Family 2014 Irrevocable Trust. Includes Shares received in the distributions described in footnote (1) above.
[F7]The shares are directly held by Starr. Includes Shares received in the distributions described in footnote (1) above.
[F8]The shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Revolution Medicines, Inc.

CIK 0001628171

→

Entity typeother

Related Parties

filerCIK 0001180428

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 6:12 PM ET
Size: 19.8 KB

View on SEC.gov